@article{37ebfeaebab74af78a69968fde894bbc,
title = "Strategies to improve pharmacogenomic-guided treatment options for patients with β-hemoglobinopathies",
author = "Patrinos, \{George P.\} and Chui, \{David H.K.\} and Hardison, \{Ross C.\} and Steinberg, \{Martin H.\}",
note = "Funding Information: GP Patrinos is full Member and National Representative at the European Medicines Agency, Committee for Human Medicinal Products (CHMP) – Pharmacogenomics Working Party, Amsterdam, the Netherlands. Support for RC Hardison is from the National Institutes of Health grants R24DK106766, R01CA178393, and R01DK054937. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. ",
year = "2021",
doi = "10.1080/17474086.2021.1977117",
language = "English (US)",
volume = "14",
pages = "883--885",
journal = "Expert Review of Hematology",
issn = "1747-4086",
publisher = "Taylor and Francis Ltd.",
number = "10",
}